... for a 2.02 credit.
Comments: Straightening up my longer-dated SPY setup, where I'm basically emulating dollar cost averaging into the broad market without actually taking a position in stock.
With the February 18th 416 at greater than 50% max, rolling it out to May to the strike paying at least 1% of the strike price in credit, after which I'll roll it up intraexpiry or out for duration at 50% max to the strike paying at least 1% in credit, assuming that strike is <16 delta. I now have March, April, and May rungs on at will continue to either roll or add at intervals with the preference being to add on weakness and higher volatility (>20 VIX/>20 30-day implied).
I've rolled this a bunch of times, collecting a total of 21.89 (See Post Below) plus the credit received here of 2.02 for a total of 23.91 relative to the 3.80 or so the May 365 is currently paying, so have realized gains of 23.91 - 3.80 = 20.11 ($2011) so far.
Comments: Straightening up my longer-dated SPY setup, where I'm basically emulating dollar cost averaging into the broad market without actually taking a position in stock.
With the February 18th 416 at greater than 50% max, rolling it out to May to the strike paying at least 1% of the strike price in credit, after which I'll roll it up intraexpiry or out for duration at 50% max to the strike paying at least 1% in credit, assuming that strike is <16 delta. I now have March, April, and May rungs on at will continue to either roll or add at intervals with the preference being to add on weakness and higher volatility (>20 VIX/>20 30-day implied).
I've rolled this a bunch of times, collecting a total of 21.89 (See Post Below) plus the credit received here of 2.02 for a total of 23.91 relative to the 3.80 or so the May 365 is currently paying, so have realized gains of 23.91 - 3.80 = 20.11 ($2011) so far.
פרסומים קשורים
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.
פרסומים קשורים
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.